Figure 2
From: Prenatal intrauterine growth restriction and risk of retinopathy of prematurity
IUGR infants, but not SGA infants, are more likely to require treatment for ROP. There was no significant association observed between the need for ROP treatment and SGA (18.6%) versus AGA (17%) status (p = 0.794 by Chi-square). In the IUGR group, 34.9% of infants (30/86) were treated for severe ROP while the infants without growth restriction were treated at a rate of 11.3% (29/257) (p < 0.0001 by Chi-square).
